Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

Share Price is delayed by 15 minutes
Get Live Data
4,788.00    -94.00 (-1.93%)
Bid:
4,780.00
Ask:
4,782.00
Spread: 2.00 (0.042%)
Market Cap: £2.23b
MGNS Live PriceLast checked at - London Stock Exchange

Intraday Morgan Sindall Group Share Chart

AGM Voting Update

4 Sep 2023 12:51

RNS Number : 3096L
Morgan Sindall Group PLC
04 September 2023
 

Morgan Sindall Group plc

Legal Entity Identifier (LEI) number: 2138008339ULDGZRB345

 

4 September 2023

Morgan Sindall Group plc ("the Company")

 

Update on response to 2023 AGM voting outcome

 

At our Annual General Meeting ('AGM') held on 4 May 2023, resolution 3 (Approval of the Directors' Remuneration Policy) was supported by a large majority of shareholders but received less than 80% support overall.

 

In advance of the 2023 AGM, the Remuneration Committee (the 'Committee') undertook a detailed engagement with the Company's largest shareholders in relation to the remuneration proposals, and had amended the final Remuneration Policy design in response to feedback received. Following the 2023 AGM, the Committee reached out to the Company's largest shareholders to continue the dialogue and listen to their views - and in particular to understand why those who either abstained or voted against the Directors' Remuneration Policy ('the 'Policy') had done so.

 

The Committee received responses from eight investors, the majority of whom reconfirmed support for the Policy and the management team. 

 

One shareholder raised the annual bonus deferral requirement and 2nd-year phasing down of the post-employment shareholding requirement as their reason for not supporting the resolution. In both cases the Committee is comfortable that its current approach supports appropriate alignment of executive and shareholder interests. In respect of the annual bonus deferral requirement, the Committee also considers this requirement appropriate given the current shareholdings of incumbent Executive Directors. However, the Committee will reconsider both of these Policy design features as part of the next Policy review.

 

The Committee also received feedback from two shareholders that their voting had reflected the 'against' recommendation from one of the major proxy voting agencies, which itself was primarily a result of the simultaneous increases to the Policy headroom available under the annual bonus and LTIP schemes. On this matter, the Committee maintains its view that the Policy should be sufficiently flexible to last for a full triennial review period rather than needing to revert to shareholders to seek incremental changes, and reiterates its commitment to write out to major shareholders in advance of using the increased maximum opportunities under either of the variable incentives.

 

Another shareholder requested that the Committee provide a full explanation in its Remuneration Report of the rationale for the adoption of any increase to the executive directors' incentive opportunities in future years, particularly in relation to the achievement of key strategic objectives, and this feedback is consistent with the current thinking of the Committee.

 

The Committee continues to be grateful for the feedback received and the two-way engagement with major shareholders. Given overall majority support was obtained for the Policy resolution, it is not proposed to make any further changes to the approach to remuneration that was set out in the 2022 Annual Report. The Company will, however, continue to keep the Policy under review over the coming years and welcomes ongoing dialogue with shareholders and proxy advisers.

 

 

Enquiries:

Clare Sheridan, Company Secretary +44 (0) 20 7307 9200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFZLFBXKLEBBF
Date   Source Headline
28th May 20147:00 amRNSDirector/PDMR Shareholding
8th May 20143:27 pmRNSAGM Statement
8th May 20147:00 amRNSAGM and Q1 Interim Management Statement
30th Apr 20149:17 amRNSTotal Voting Rights
3rd Apr 20148:48 amRNSDirector/PDMR Shareholding
26th Mar 20148:30 amRNSAnnual Financial Report
19th Mar 20144:54 pmRNSHolding(s) in Company
18th Mar 20145:02 pmRNSBlocklisting Interim Review
17th Mar 20143:31 pmRNSDirector/PDMR Shareholding
27th Feb 20144:47 pmRNSTotal Voting Rights
18th Feb 20147:00 amRNSFinal Results
31st Jan 201412:23 pmRNSTotal Voting Rights
23rd Dec 20134:12 pmRNSTotal Voting Rights
13th Dec 20137:00 amRNSBoard Change
29th Nov 20134:26 pmRNSTotal Voting Rights
7th Nov 20137:00 amRNSInterim Management Statement
31st Oct 20132:18 pmRNSTotal Voting Rights
9th Oct 20134:41 pmRNSHolding(s) in Company
30th Sep 20134:48 pmRNSTotal Voting Rights
27th Sep 20131:22 pmRNSDirector/PDMR Shareholding
25th Sep 20135:01 pmRNSHolding(s) in Company
17th Sep 201310:06 amRNSHolding(s) in Company
30th Aug 20133:51 pmRNSTotal Voting Rights
13th Aug 20134:41 pmRNSHolding(s) in Company
13th Aug 201312:04 pmRNS£100m South Shields Regeneration Project
12th Aug 201311:47 amRNSNotifications of Major Interests in Shares
9th Aug 20131:11 pmRNSDirector/PDMR Shareholding
9th Aug 201312:00 pmRNSHolding(s) in Company
5th Aug 20137:00 amRNSHalf Yearly Report
31st Jul 20133:08 pmRNSTotal Voting Rights
11th Jul 20137:00 amRNS£269m Woolwich Redevelopment Programme Award
2nd Jul 20139:23 amRNSDirector Declaration
28th Jun 20132:45 pmRNSTotal Voting Rights
28th Jun 20137:19 amRNSDisposal of PFI interest
26th Jun 20134:17 pmRNSHolding(s) in Company
11th Jun 201310:30 amRNSHolding(s) in Company
31st May 201311:45 amRNSTotal Voting Rights
30th May 20138:11 amRNSBlocklisting Interim Review
24th May 20139:30 amRNSHolding(s) in Company
9th May 20131:53 pmRNSResult of AGM
9th May 20137:00 amRNSAGM and Q1 Interim Management Statement
7th May 20139:00 amRNSMuse Developments appointed preferred bidder
30th Apr 20131:53 pmRNSTotal Voting Rights
16th Apr 20137:00 amRNSLovell signs £63.3m Dagenham homes scheme
8th Apr 201310:12 amRNSHolding(s) in Company
2nd Apr 20139:45 amRNSHolding(s) in Company
28th Mar 20135:22 pmRNSHolding(s) in Company
28th Mar 20133:04 pmRNSTotal Voting Rights
26th Mar 20133:36 pmRNSAnnual Financial Report
20th Mar 20135:36 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.